71 related articles for article (PubMed ID: 23906866)
1. Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications.
Mejías R; Gutiérrez L; Salas G; Pérez-Yagüe S; Zotes TM; Lázaro FJ; Morales MP; Barber DF
J Control Release; 2013 Oct; 171(2):225-33. PubMed ID: 23906866
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility and proteomic profiling of DMSA-coated iron nanocubes in a human glioblastoma cell line.
Ulanova M; Gloag L; Kim CK; Bongers A; Kim Duong HT; Gooding JJ; Tilley RD; Sachdev PS; Braidy N
Nanomedicine (Lond); 2024 Feb; 19(4):303-323. PubMed ID: 38270934
[TBL] [Abstract][Full Text] [Related]
3. Potential Use of DMSA-Containing Iron Oxide Nanoparticles as Magnetic Vehicles against the COVID-19 Disease.
Martins ES; Espindola A; Britos TN; Chagas C; Barbosa E; Castro CE; Fonseca FLA; Haddad PS
ChemistrySelect; 2021 Aug; 6(31):7931-7935. PubMed ID: 34541297
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer.
Carneiro ML; Peixoto RC; Joanitti GA; Oliveira RG; Telles LA; Miranda-Vilela AL; Bocca AL; Vianna LM; da Silva IC; de Souza AR; Lacava ZG; Báo SN
J Nanobiotechnology; 2013 Feb; 11():4. PubMed ID: 23414068
[TBL] [Abstract][Full Text] [Related]
5. Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles.
Sharma A; Cornejo C; Mihalic J; Geyh A; Bordelon DE; Korangath P; Westphal F; Gruettner C; Ivkov R
Sci Rep; 2018 Mar; 8(1):4916. PubMed ID: 29559734
[TBL] [Abstract][Full Text] [Related]
6. The role of ROS generation from magnetic nanoparticles in an alternating magnetic field on cytotoxicity.
Wydra RJ; Rychahou PG; Evers BM; Anderson KW; Dziubla TD; Hilt JZ
Acta Biomater; 2015 Oct; 25():284-90. PubMed ID: 26143604
[TBL] [Abstract][Full Text] [Related]
7. In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms.
Kim Y; Kong SD; Chen LH; Pisanic TR; Jin S; Shubayev VI
Nanomedicine; 2013 Oct; 9(7):1057-66. PubMed ID: 23669369
[TBL] [Abstract][Full Text] [Related]
8. DMSA-coated IONPs trigger oxidative stress, mitochondrial metabolic reprograming and changes in mitochondrial disposition, hindering cell cycle progression of cancer cells.
Daviu N; Portilla Y; Gómez de Cedrón M; Ramírez de Molina A; Barber DF
Biomaterials; 2024 Jan; 304():122409. PubMed ID: 38052135
[TBL] [Abstract][Full Text] [Related]
9. Quantification and biodegradability assessment of meso-2,3-dimercaptosuccinic acid adsorbed on iron oxide nanoparticles.
Bemowsky S; Rother A; Willmann W; Köser J; Markiewicz M; Dringen R; Stolte S
Nanoscale Adv; 2019 Sep; 1(9):3670-3679. PubMed ID: 36133553
[TBL] [Abstract][Full Text] [Related]
10. Glutathione-mediated biotransformation in the liver modulates nanoparticle transport.
Jiang X; Du B; Zheng J
Nat Nanotechnol; 2019 Sep; 14(9):874-882. PubMed ID: 31308501
[TBL] [Abstract][Full Text] [Related]
11. Iron Speciation in Animal Tissues Using AC Magnetic Susceptibility Measurements: Quantification of Magnetic Nanoparticles, Ferritin, and Other Iron-Containing Species.
Fernández-Afonso Y; Asín L; Beola L; Moros M; M de la Fuente J; Fratila RM; Grazú V; Gutiérrez L
ACS Appl Bio Mater; 2022 May; 5(5):1879-1889. PubMed ID: 35179873
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution Analysis of Peptide-Coated Magnetic Iron Nanoparticles: A Simple and Quantitative Method.
Natarajan P; Horak K; Rowe J; Yoon S; Lingo J; Tomich JM; Fleming SD
Mol Pharm; 2024 Feb; 21(2):970-981. PubMed ID: 38206824
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution Analysis of Peptide-Coated Magnetic Iron Nanoparticles: A Simple and Quantitative Method.
Natarajan P; Horak K; Rowe J; Lingo J; Tomich JM; Fleming SD
bioRxiv; 2023 Oct; ():. PubMed ID: 37873129
[TBL] [Abstract][Full Text] [Related]
14. Progressive lysosomal membrane permeabilization induced by iron oxide nanoparticles drives hepatic cell autophagy and apoptosis.
Levada K; Pshenichnikov S; Omelyanchik A; Rodionova V; Nikitin A; Savchenko A; Schetinin I; Zhukov D; Abakumov M; Majouga A; Lunova M; Jirsa M; Smolková B; Uzhytchak M; Dejneka A; Lunov O
Nano Converg; 2020 May; 7(1):17. PubMed ID: 32424769
[TBL] [Abstract][Full Text] [Related]
15. Recent trends in preparation and biomedical applications of iron oxide nanoparticles.
Meng YQ; Shi YN; Zhu YP; Liu YQ; Gu LW; Liu DD; Ma A; Xia F; Guo QY; Xu CC; Zhang JZ; Qiu C; Wang JG
J Nanobiotechnology; 2024 Jan; 22(1):24. PubMed ID: 38191388
[TBL] [Abstract][Full Text] [Related]
16. 3,4-Dihydroxiphenylacetic Acid-Based Universal Coating Technique for Magnetic Nanoparticles Stabilization for Biomedical Applications.
Semkina A; Nikitin A; Ivanova A; Chmelyuk N; Sviridenkova N; Lazareva P; Abakumov M
J Funct Biomater; 2023 Sep; 14(9):. PubMed ID: 37754875
[TBL] [Abstract][Full Text] [Related]
17. Photothermia at the nanoscale induces ferroptosis via nanoparticle degradation.
Fromain A; Perez JE; Van de Walle A; Lalatonne Y; Wilhelm C
Nat Commun; 2023 Aug; 14(1):4637. PubMed ID: 37532698
[TBL] [Abstract][Full Text] [Related]
18. Different coatings on magnetic nanoparticles dictate their degradation kinetics in vivo for 15 months after intravenous administration in mice.
Portilla Y; Fernández-Afonso Y; Pérez-Yagüe S; Mulens-Arias V; Morales MP; Gutiérrez L; Barber DF
J Nanobiotechnology; 2022 Dec; 20(1):543. PubMed ID: 36578018
[TBL] [Abstract][Full Text] [Related]
19. Influence of Polymer Shell Molecular Weight on Functionalized Iron Oxide Nanoparticles Morphology and In Vivo Biodistribution.
Popescu RC; Vasile BŞ; Savu DI; Mogoşanu GD; Bejenaru LE; Andronescu E; Grumezescu AM; Mogoantă L
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145625
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
